Lactate acidifies the tumor cell microenvironment, which inhibits the anti-tumor immune response, influences CTLA-4 production via the EPAC1 signaling pathway, and strengthens its capacity to prevent effector T cell activation (Fischbeck et al., 2020). This evidence concerns the gene RAPGEF3 and neoplasm.